GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 18.05
+0.05 (0.28%)
Jan 22, 2026, 11:39 AM CST
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.55 billion as of January 21, 2026. Its market cap has decreased by -9.62% in one year.
Market Cap
1.55B
Enterprise Value
1.45B
Revenue
391.48M
Ranking
n/a
PE Ratio
46.16
Stock Price
18.05
Market Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.55B, an increase of 72.18%. That is a compound annual growth rate of 2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.55B | -1.91% |
| Dec 31, 2025 | 1.58B | -9.68% |
| Dec 31, 2024 | 1.75B | -18.22% |
| Dec 29, 2023 | 2.14B | 4.39% |
| Dec 30, 2022 | 2.05B | -2.67% |
| Dec 30, 2021 | 2.10B | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 2.17B |
| Chunghwa Chemical Synthesis & Biotech | 2.02B |
| Genomics BioSci & Tech. | 1.78B |
| Great Novel Therapeutics Biotech & Medicals | 1.74B |
| NeoCore Technology | 1.58B |
| Advagene Biopharma | 1.56B |
| Enimmune corporation | 1.51B |
| Abnova (Taiwan) | 1.47B |